Rita Medical's RFA surgical resector:
This article was originally published in Clinica
Rita Medical Systems has gained the all-clear in the US to sell a radiofrequency ablation (RFA) surgical resection tool that limits blood loss by coagulating blood before any tissue is excised. The HABIB4X resection device, which is also CE-marked for sale in Europe, is expected to be used in liver cancer surgery, said the Fremont, California firm. It is also designed to work with the company's current RFA platform of 1500X generators. Rita Medical added the resection device to its stable of products after signing an exclusive worldwide licence deal with EMcision (see Clinica No 1160, p 18).
You may also be interested in...
Operation Warp Speed will hold back initial shipments to ensure two-dose regimens can be completed; 15 December is ‘chalk’ target date for emergency authorization of Pfizer vaccine, OWS’ Gustave Perna says, calling it only a projection that does not impinge on FDA authority. Sending only half shipments also eases burden on cold shortage capacity at state and local level, he says.
CMS acknowledges stakeholders may need more details about the plan before it is finalized and a delay will give the agency more time to ‘consider the issue.’
Private Company Edition: Venture capital financings didn’t take a break during Thanksgiving week. In addition to the $800m Resilience raised to fund manufacturing services, SomaLogic closed a $121m series A round to fund its proteomic tools for drug discovery and diagnostics development.